Hostname: page-component-7bb8b95d7b-w7rtg Total loading time: 0 Render date: 2024-09-24T12:12:02.271Z Has data issue: false hasContentIssue false
  • English
  • Français

Community-Acquired Clostridium difficile–Associated Diarrhea, Montréal, 2005–2006: Frequency Estimates and Their Validity

Published online by Cambridge University Press:  02 January 2015

Robert Allard ,
André Dascal ,
Bakary Camara ,
Josiane Létourneau  and
Louise Valiquette
Robert Allard*
Affiliation:
Public Health Department, Montréal Health and Social Services Agency, Montréal, Québec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
André Dascal
Affiliation:
Public Health Department, Montréal Health and Social Services Agency, Montréal, Québec, Canada Department of Microbiology, McGill University, Montréal, Québec, Canada
Bakary Camara
Affiliation:
Public Health Department, Montréal Health and Social Services Agency, Montréal, Québec, Canada
Josiane Létourneau
Affiliation:
Public Health Department, Montréal Health and Social Services Agency, Montréal, Québec, Canada Department of Nursing, Université de Montréal, Montréal, Québec, Canada
Louise Valiquette
Affiliation:
Public Health Department, Montréal Health and Social Services Agency, Montréal, Québec, Canada Department of Social and Preventive Medicine, Université de Montréal, Montréal, Québec, Canada
*
Direction de santé publique, ASSS, 1301 rue Sherbrooke Est, Montréal, QC H2L 1M3, Canada (rallard@ santepub-mtl.qc.ca)
Get access Rights & Permissions [Opens in a new window]

Abstract

A retrospective search for community-acquired Clostridium difficile-associated diarrhea in 15 hospitals revealed important discrepancies with numbers for the same period reported in real time to the surveillance system. Several of the observed problems could be solved by implementing case-by-case notification with subsequent investigation by local public health, as for other reportable diseases.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 10 , October 2011 , pp. 1032 - 1034
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Freeman, J, Bauer, MP, Baines, SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23(3):529–548.CrossRefGoogle ScholarPubMed
2. McDonald, LC, Coignard, B, Dubberke, E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140–145.CrossRefGoogle ScholarPubMed
3. Dial, S, Kezouh, A, Dascal, A, Barkun, A, Suissa, S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008;179(8):767–772.CrossRefGoogle ScholarPubMed
4. Kutty, PK, Benoit, SR, Woods, CW, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008;29(3):197–202.CrossRefGoogle ScholarPubMed
5. Lin, MY, Hota, B, Khan, YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304(18):2035–2041.CrossRefGoogle ScholarPubMed
6. McBryde, ES, Brett, J, Russo, PL, Worth, LJ, Bull, AL, Richards, MJ. Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia. Infect Control Hosp Epidemiol 2009;30(11):1045–1049.CrossRefGoogle ScholarPubMed
7. Berrington, A, Borriello, SP, Brazier, J, et al. National Clostridium difficile Standards Group: report to the Department of Health. J Hosp Infect 2004;56(1):1–38.Google Scholar
8. Panel 2: surveillance for disease and sources of infection. In: Emerging Clostridial Disease Workshop, May 11, 2006, Atlanta, Georgia: summary of proceedings. 2006:25–32. http://www.fda.gov/downloads/AboutFDA/CentersOfnces/CDER/UCM183030.pdf.Google Scholar
9. Kuijper, EJ, Coignard, B, Tiill, P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12(suppl 6):2–18.CrossRefGoogle Scholar
10. Rabatsky-Ehr, T, Purviance, K, Mlynarski, D, Mshar, P, Hadler, J, Sosa, L. Surveillance for community-associated Clostridium difficile: Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57(13):340–343.Google Scholar
11. Doherty, JA. Final report and recommendations from the National Notifiable Diseases Working Group. Can Commun Dis Rep 2006;32(19):211–225.Google ScholarPubMed